Cornelis P M Van Kessel

Title: Cornelis P M Van Kessel: Innovator in Polypeptide Research

Introduction

Cornelis P M Van Kessel is a notable inventor based in Bunnik, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the development of polypeptides with therapeutic applications. With a total of 2 patents, his work focuses on innovative solutions for medical challenges.

Latest Patents

Van Kessel's latest patents include groundbreaking inventions related to polypeptides and their uses. One patent describes a polypeptide that exhibits the biological activity of the Chemotaxis Inhibitory Protein (CHIPS). This polypeptide comprises variants of a specific amino acid sequence, with modifications aimed at reducing immunogenicity in humans compared to the wildtype CHIPS protein. Another patent involves nucleic acids encoding polypeptides with CHIPS activity, along with methods for preparing these recombinant (poly)peptides. These inventions have potential applications in the diagnosis, prophylaxis, and treatment of conditions such as inflammation reactions and HIV.

Career Highlights

Cornelis P M Van Kessel is currently associated with Alligator Bioscience AB, where he continues to advance his research in polypeptide technology. His work has positioned him as a key figure in the biopharmaceutical industry, contributing to the development of innovative therapeutic solutions.

Collaborations

Throughout his career, Van Kessel has collaborated with esteemed colleagues, including Johannes A G Van Strijp and Andreas Paul Peschel. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological advancements.

Conclusion

Cornelis P M Van Kessel's contributions to polypeptide research exemplify the impact of innovation in the field of biochemistry. His patents and ongoing work at Alligator Bioscience AB highlight the importance of scientific advancements in addressing critical health issues.